Variables and Strategies in Development of Therapeutic Post-Transcriptional Gene Silencing Agents

Post-transcriptional gene silencing (PTGS) agents such as ribozymes, RNAi and antisense have substantial potential for gene therapy of human retinal degenerations. These technologies are used to knockdown a specific target RNA and its cognate protein. The disease target mRNA may be a mutant mRNA c...

Full description

Saved in:
Bibliographic Details
Main Authors: Jack M. Sullivan, Edwin H. Yau, Tiffany A. Kolniak, Lowell G. Sheflin, R. Thomas Taggart, Heba E. Abdelmaksoud
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2011/531380
Tags: Add Tag
No Tags, Be the first to tag this record!